Chronic bone infections due to Enterobacter cloacae: current therapeutic trends and clinical outcome

J Chemother. 2009 Apr;21(2):226-8. doi: 10.1179/joc.2009.21.2.226.

Authors

K Kanellakopoulou¹, E Giannitsioti, A Papadopoulos, S Athanassia, E J Giamarellos-Bourboulis, H Giamarellou

Affiliation

¹ 4th Department of Internal Medicine, University of Athens, Greece.

PMID: 19423480
DOI: 10.1179/joc.2009.21.2.226

No abstract available

MeSH terms

Adolescent
Adult
Aged
Anti-Bacterial Agents / therapeutic use
Bone Diseases, Infectious / drug therapy*
Bone Diseases, Infectious / surgery*
Carbapenems / therapeutic use
Chronic Disease
Ciprofloxacin / therapeutic use
Combined Modality Therapy
Debridement
Drug Resistance, Multiple, Bacterial
Enterobacter cloacae
Enterobacteriaceae Infections / drug therapy*
Enterobacteriaceae Infections / surgery*
Female
Humans
Male
Middle Aged
Retrospective Studies
Young Adult

Substances

Anti-Bacterial Agents
Carbapenems
Ciprofloxacin